| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $271.1M | $452.7M | $238.7M |
| YoY Revenue Growth % | -40.1% | +89.6% | — |
| Gross Profit | $46.0M | $182.9M | — |
| Gross Margin % | 17.0% | 40.4% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$378.2M | $54.5M | -$49.2M |
| Operating Margin % | -80.0% | 12.0% | -20.6% |
| Net Income (GAAP) | -$389.6M | $13.4M | -$45.8M |
| EBITDA (Normalized) | -$348.3M | $123.5M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $32.9M | $45.5M | -$42.6M |
| Capital Expenditures (CapEx) | $37.4M | $86.3M | — |
| Free Cash Flow (FCF) | -$4.6M | -$40.7M | -$42.6M |
| FCF Margin % | -1.7% | -9.0% | -17.9% |
| Return on Invested Capital (ROIC %) | -45.0% | 10.9% | — |
| Cash & Short-Term Equivalents | $156.9M | $220.9M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $235.5M | $614.7M | — |